Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9015 |
High Similarity |
NPD7266 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7863 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7708 |
Intermediate Similarity |
NPD6190 |
Approved |
0.752 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7424 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7422 |
Intermediate Similarity |
NPD969 |
Suspended |
0.7386 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7343 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7343 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7302 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7203 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7083 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7083 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.708 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7067 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7042 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD3764 |
Approved |
0.6988 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6985 |
Remote Similarity |
NPD1357 |
Approved |
0.6978 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD8312 |
Approved |
0.6946 |
Remote Similarity |
NPD8313 |
Approved |
0.694 |
Remote Similarity |
NPD7157 |
Approved |
0.6923 |
Remote Similarity |
NPD2684 |
Approved |
0.6897 |
Remote Similarity |
NPD1613 |
Approved |
0.6897 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6886 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD37 |
Approved |
0.6875 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6875 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6867 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6864 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6855 |
Remote Similarity |
NPD4966 |
Approved |
0.6855 |
Remote Similarity |
NPD4965 |
Approved |
0.6855 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD290 |
Approved |
0.6835 |
Remote Similarity |
NPD3705 |
Approved |
0.6835 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6821 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6821 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD7095 |
Approved |
0.6803 |
Remote Similarity |
NPD6653 |
Approved |
0.68 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6781 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6774 |
Remote Similarity |
NPD2933 |
Approved |
0.6774 |
Remote Similarity |
NPD2934 |
Approved |
0.6774 |
Remote Similarity |
NPD5403 |
Approved |
0.6772 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6765 |
Remote Similarity |
NPD694 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD9493 |
Approved |
0.6763 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6757 |
Remote Similarity |
NPD4538 |
Approved |
0.6757 |
Remote Similarity |
NPD4536 |
Approved |
0.6757 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6755 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6736 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6735 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6726 |
Remote Similarity |
NPD7240 |
Approved |
0.672 |
Remote Similarity |
NPD2859 |
Approved |
0.672 |
Remote Similarity |
NPD2860 |
Approved |
0.6718 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD5535 |
Approved |
0.6712 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6711 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.671 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6691 |
Remote Similarity |
NPD4198 |
Discontinued |
0.669 |
Remote Similarity |
NPD8651 |
Approved |
0.669 |
Remote Similarity |
NPD3225 |
Approved |
0.6688 |
Remote Similarity |
NPD6799 |
Approved |
0.6688 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6667 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD5736 |
Approved |
0.6667 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD5401 |
Approved |
0.6645 |
Remote Similarity |
NPD3536 |
Discontinued |
0.6644 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6643 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6639 |
Remote Similarity |
NPD689 |
Discontinued |
0.6623 |
Remote Similarity |
NPD5762 |
Approved |
0.6623 |
Remote Similarity |
NPD5763 |
Approved |
0.6622 |
Remote Similarity |
NPD1933 |
Approved |
0.6621 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6604 |
Remote Similarity |
NPD7411 |
Suspended |
0.66 |
Remote Similarity |
NPD5588 |
Approved |
0.66 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6597 |
Remote Similarity |
NPD5647 |
Approved |
0.6596 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6594 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6589 |
Remote Similarity |
NPD940 |
Approved |
0.6589 |
Remote Similarity |
NPD846 |
Approved |
0.6585 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6584 |
Remote Similarity |
NPD5402 |
Approved |
0.6583 |
Remote Similarity |
NPD111 |
Approved |
0.6579 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6571 |
Remote Similarity |
NPD4626 |
Approved |
0.6571 |
Remote Similarity |
NPD5238 |
Clinical (unspecified phase) |
0.6569 |
Remote Similarity |
NPD6671 |
Approved |
0.6568 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6566 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD1934 |
Approved |
0.6562 |
Remote Similarity |
NPD3020 |
Approved |
0.6556 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6552 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD8319 |
Approved |
0.6538 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6538 |
Remote Similarity |
NPD6647 |
Phase 2 |
0.6536 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6531 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6528 |
Remote Similarity |
NPD2797 |
Approved |
0.6528 |
Remote Similarity |
NPD6362 |
Approved |
0.6525 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6522 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD7819 |
Suspended |
0.6519 |
Remote Similarity |
NPD228 |
Approved |
0.6516 |
Remote Similarity |
NPD5756 |
Phase 2 |
0.6515 |
Remote Similarity |
NPD968 |
Approved |
0.6513 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6513 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6507 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6503 |
Remote Similarity |
NPD3685 |
Discontinued |
0.65 |
Remote Similarity |
NPD5691 |
Approved |
0.65 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6494 |
Remote Similarity |
NPD3750 |
Approved |
0.6493 |
Remote Similarity |
NPD3022 |
Approved |
0.6493 |
Remote Similarity |
NPD3021 |
Approved |
0.6488 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6486 |
Remote Similarity |
NPD6663 |
Approved |
0.6485 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6484 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6483 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6481 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.648 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.648 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6479 |
Remote Similarity |
NPD1535 |
Discovery |
0.6479 |
Remote Similarity |
NPD3092 |
Approved |
0.6478 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6475 |
Remote Similarity |
NPD1282 |
Approved |
0.6463 |
Remote Similarity |
NPD3179 |
Approved |
0.6463 |
Remote Similarity |
NPD3180 |
Approved |
0.6463 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6457 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6454 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6454 |
Remote Similarity |
NPD5846 |
Approved |
0.6454 |
Remote Similarity |
NPD1778 |
Approved |
0.645 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.645 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6447 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6443 |
Remote Similarity |
NPD4140 |
Approved |
0.6442 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6439 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6439 |
Remote Similarity |
NPD9697 |
Approved |
0.6438 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6438 |
Remote Similarity |
NPD9494 |
Approved |
0.6437 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6434 |
Remote Similarity |
NPD9717 |
Approved |
0.6434 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6434 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6432 |
Remote Similarity |
NPD7585 |
Approved |
0.6429 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6429 |
Remote Similarity |
NPD7741 |
Discontinued |
0.6423 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6419 |
Remote Similarity |
NPD3268 |
Approved |
0.6419 |
Remote Similarity |
NPD1048 |
Approved |
0.6415 |
Remote Similarity |
NPD3686 |
Approved |
0.6415 |
Remote Similarity |
NPD3687 |
Approved |
0.6414 |
Remote Similarity |
NPD1203 |
Approved |
0.6414 |
Remote Similarity |
NPD4103 |
Phase 2 |
0.6414
|
Remote Similarity |
NPD4104 |
Clinical (unspecified phase) |